Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Liraglutide: Phase II data

In a Phase II trial of 564 non-diabetic patients weighing 100 kg, 20 weeks of treatment

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE